Israeli deep tech fund VentureIsrael has invested in med tech startup NeuroBrave.
Follow Israel Hayom on Facebook and Twitter
NeuroBrave uses cloud-based infrastructure, advanced signal processing and Deep Neural Networks proprietary algorithms to create a standardized software solution (NeuroSpeed OS) to provide cognitive states and neuromarkers insights using any hardware, including earphones, smartwatches, and other wearables.
"As the world of technology moves toward more and more personalization, NeuroBrave's solution offering real-time high accuracy insights on cognitive, physiological and mental states is extremely relevant right now," says Roman Gold, Managing General Partner of VentureIsrael, who was appointed Board Observer at NeuroBrave.
"We are super excited to have VentureIsrael as our investor, with a growing reputation to become leaders in the Israeli VC industry, vast experience in global markets, network and financial expertise from Seed to IPO. Our extraordinary team of specialists at NeuroBrave was able to develop a unique SaaS solution that we're now deploying with global enterprises and SMBs, enabling them to provide their users in consumer and professional markets new real-time tools for wellness, productivity, performance, and safety by understanding state of mind, emotions and cognitive insights in a very accessible and intuitive way," said Dror Talisman, co-founder and CEO of NeuroBrave.
